IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Total Operating Expense: ₹6,432 Mil (TTM As of Mar. 2026)


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
63 GF Score
Price ₹133.66
GF Value ₹93.67
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Total Operating Expense?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +2.06% 63 Total Operating Expense is ₹6,432 Mil as of Mar. 2026. GuruFocus rates NSE:IOLCP with a GF Score™ of 63/100 and a GF Value™ of ₹93.67 (Significantly Overvalued). The stock has 5 warning signs investors should review.

IOL Chemicals And Pharmaceuticals's Total Operating Expense for the three months ended in Mar. 2026 was ₹1,750 Mil. IOL Chemicals And Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6,432 Mil.

IOL Chemicals And Pharmaceuticals Total Operating Expense Related Terms

IOL Chemicals And Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Total Operating Expense Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,555.20 4,448.10 5,279.30 5,570.50 6,432.20

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,377.90 1,450.90 1,622.70 1,608.50 1,750.10
NSE:IOLCP
63GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,432 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹6,432 Mil mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Total Operating Expense of ₹6,432 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on IOL Chemicals And Pharmaceuticals and its competitors.
Is IOL Chemicals And Pharmaceuticals' Total Operating Expense too high?
IOL Chemicals And Pharmaceuticals' current Total Operating Expense is ₹6,432 Mil. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Total Operating Expense compare to ZTS?
IOL Chemicals And Pharmaceuticals' Total Operating Expense of ₹6,432 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. IOL Chemicals And Pharmaceuticals's current Total Operating Expense is ₹6,432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.67, compared to a current price of ₹133.66 — trading 42.7% above its estimated fair value. The current Total Operating Expense is ₹6,432 Mil. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Total Operating Expense is ₹6,432 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹133.66 is trading 42.7% above its estimated GF Value™ of ₹93.67. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Total Operating Expense: ₹6,432 Mil
  • GF Value™: ₹93.67 vs. price of ₹133.66 (42.7% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
63GF Score

Get the complete analysis for NSE:IOLCP

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹133.66
Price
₹93.67
GF Value